Nico P.E. Vermeulen (MSc in Chemistry (Univ. of Nijmegen, 1975) and a PhD in Pharmacology (Univ. of Leiden, 1980)), was appointed professor of Molecular Toxicology in the Department of Chemistry and Pharmaceutical Sciences (CPS) at VU University Amsterdam, in 1985. He was Head of the Department of CPS (2009 – 2015) and Director of AIMMS (Amsterdam Institute of Molecules, Medicines and Systems; (2010 – 2017); www.aimms.vu.nl). Amongst others, he (is/was) coordinator of SafeSciMET, an IMI-JU consortium and WP-Leader in two other large IMI-JU consortia: eTOX and MIP-DILI.
He was awarded with the European ISSX Scientific Achievement Award (2006), an Honorary Doctorate from the Univ. of Copenhagen (2011), the ISSX Distinguished Service Award (2016) and he is a Life-time Honorary Member of ISSX. He was elected and acted as President of ISSX (2000 - 2005).
His general research interests are concerned with the Roles Molecular and Computational Toxicology can play in Drug discovery, development and safety assessment. More specifically, he is interested in toxication/detoxication mechanisms, in silico and in vitro prediction and screening of ADME-Tox properties, (biocatalytic) metabolite production and profiling and translational biomarkers of adverse drug reactions (ADRs).
He is author / co-author of more than 425 scientific publications in the fields of Molecular Toxicology, Pharmacology, Bioanalysis and Medicinal Chemistry. In 2010 and 2015, he was listed as highly-cited author at www.ISIHighlyCited.com. He was/is Editor in Chief of Environmental Toxicology & Pharmacology (2001-2017), Associate-Editor of Current Drug Metabolism (CDM, 2007 - ) and Drug Metabolism Letters (DML. 2007 - ) and a member of the Editorial Boards of 12 International Scientific Journals. See: https://research.vu.nl/en/persons/npe-vermeulen
